Automated plant factory for the prodution of vaccines

June 11, 2013, Fraunhofer-Gesellschaft
Professor Vidadi Yusibov and Professor Andre Sharon (from left to right) in the fully automated plant factory. Credit: Dirk Mahler/Fraunhofer

Molecular farming is an easy, fast, and safe method for producing vaccines and therapeutic proteins in plants. Now a team of Fraunhofer researchers from the USA has built up a Good Manufacturing Practices (GMP) compliant plant factory.

The during the in 2009 showed that although chicken- is a reliable method, in a global emergency, it takes too long and does not yield enough vaccine. What is required are alternative methods with shorter production times and larger capacity, such as the production of vaccines and therapeutic agents in plants for example. Molecular farming, as this method is known in the trade, is easy, fast, and safe: the genetic information needed for production is introduced into the plant via virus vectors that are harmless to humans. Moreover, plants have machinery similar to that of humans and can accommodate complex proteins.

"We use tobacco plants because they multiply and maintain our virus vectors very well. In addition, they grow fast yielding, large quantities of biomass in a short period of time," says Vidadi Yusibov from the Fraunhofer Center for Molecular Biotechnology (CMB). It has already been demonstrated in the laboratory that the method works well. But can this approach be scaled for mass production? The researchers have already cleared the first hurdles: they have developed a fully integrated, automated, GMP facility – a fundamental prerequisite for the production of biopharmaceuticals. In recognition of this achievement, one of this year's Joseph von Fraunhofer prizes is being awarded to two Fraunhofer researchers from the United States: Prof. Dr. Andre Sharon from the Fraunhofer Center for Manufacturing Innovation (partner institute of the Fraunhofer Institute for Production Technology IPT) and Prof. Dr. Vidadi Yusibov from the Fraunhofer Center for (partner institute of the Fraunhofer Institute for and Applied Ecology IME).

Plants with predictable quality – any time, any place

The decisive moment was receiving a contract from the U.S. government's Defense Advanced Research Projects Agency (DARPA), which was looking for vaccine production alternatives. "Once some initial difficulties in understanding each other were overcome, our teams of biologists and engineers succeeded in building up our automated plant-based vaccine production factory. Now we have plants that consistently grow and make proteins to the same predictable quality, time after time whenever and wherever we like – crazy as that might sound!" says Andre Sharon from Fraunhofer CMI and Professor of Engineering at Boston University.

The plants grow in trays with hydroponic cultures of mineral wool as opposed to soil, in specially designed growth modules. Light, water, and nutrients are precisely dosed and distributed. Specially developed robots bring the plants from station to station to carry out the various steps – from inserting the tiny seeds and vacuum infiltration, to harvesting and extraction.

The plants grow for four weeks before the vector is introduced by means of vacuum infiltration. This process goes as follows: A robot picks up a tray with plants, turns it upside down, and submerges the headfirst into water. "This water holds the vector (biological carrier) containing the genetic information that tells the plants which protein they should produce. Then a vacuum is applied by drawing the air from the water and the plants. As soon as we switch off the vacuum, the plants suck in the water together with the vector. This takes just a few seconds," explains Sharon. Then the are put back in the growth module to grow further. In about a week they have produced the proteins. Once harvested, the leaves are cut into small pieces and homogenized in fully automated processes. This produces a liquid, from which the proteins are extracted. The end product is a clear liquid.

The pilot facility is capable of producing up to 300 kilograms of biomass a month, which roughly corresponds to 2.5 million units of vaccine.

Explore further: Medicines from plants

Related Stories

Medicines from plants

May 26, 2011

Some people think of herbal teas, others of tobacco when they hear the buzzword "medicines from plants". One research team succeeded in producing biopharmaceuticals -- such as an antibody against HIV, for example, -- in tobacco ...

Giant tobacco plants that stay young forever

January 7, 2013

Tobacco plants bloom when they are just a few months old – and then they die. Now, researchers have located a genetic switch which can keep the plants young for years and which permits unbounded growth. In short, an ideal ...

Plants 'talk' to plants to help them grow

May 6, 2013

Having a neighborly chat improves seed germination, finds research in BioMed Central's open access journal BMC Ecology. Even when other known means of communication, such as contact, chemical and light-mediated signals, are ...

Repairing turbines with the help of robots

June 5, 2013

Compressor and turbine blades are important components in aircraft engines and gas turbines. When they become damaged, it is often cheaper to repair them than to buy replacements. Now there is a new robot-assisted technique ...

New meds faster

April 8, 2010

Before a new medication arrives on the market, it must be tested on animal models and in humans. In order to conduct these tests, a substantial amount of the therapeutically effective substances are needed - such as proteins ...

Recommended for you

Scientists engineer new CRISPR platform for DNA targeting

January 23, 2019

A team that includes the scientist who first harnessed the revolutionary CRISPR-Cas9 and other systems for genome editing of eukaryotic organisms, including animals and plants, has engineered another CRISPR system, called ...

Human mutation rate has slowed recently

January 23, 2019

Researchers from Aarhus University, Denmark, and Copenhagen Zoo have discovered that the human mutation rate is significantly slower than for our closest primate relatives. This new knowledge may be important for estimates ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.